Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 2, 2013, Pages 190-196

  Sun, Bing ^a   Abadjian, Linda ^a   Rempel, Hans ^a   Monto, Alexander ^b   Pulliam, Lynn ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis C virus; HIV; neuropsychological test

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; EXECUTIVE FUNCTION; GLOBAL DEFICIT SCORE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; LEARNING; LIVER CIRRHOSIS; MALE; MIXED INFECTION; MOTOR ACTIVITY; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCORING SYSTEM; VERBAL MEMORY; VIRUS LOAD; VISUAL MEMORY; WORKING MEMORY;

ATTENTION; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; COINFECTION; CROSS-SECTIONAL STUDIES; DEPRESSION; EXECUTIVE FUNCTION; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; VERBAL LEARNING; VIRAL LOAD;

EID: 84872872139     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827b61f1     Document Type: Article

References (38)

1. Monto A, Schooley RT, Lai JC, et al. Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop. Am J Gastroenterol. 2010;105:989-1004; quiz 1988, 1005.
2. Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS. 2010;24:1537-1548.
3. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558-567. (Pubitemid 41196755)
4. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a crosssectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-837. (Pubitemid 34194855)
5. Cargill VA. HIV/hepatitis C virus co-infection: its human face. AIDS. 2005;19(suppl 3):S1-S2. (Pubitemid 41682161)
6. Clifford DB, Evans SR, Yang Y, et al. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS. 2005;19(suppl 3):S64-S71. (Pubitemid 41682171)
7. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35:433-439. (Pubitemid 34106386)
8. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002;35:440-446. (Pubitemid 34106387)
9. Ryan EL, Morgello S, Isaacs K, et al. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62:957-962. (Pubitemid 38435785)
10. von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, et al. Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr. 2004;35:131-137. (Pubitemid 38133735)
11. Perry W, Carlson MD, Barakat F, et al. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS. 2005;19(suppl 3):S79-S84. (Pubitemid 41682173)
12. Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005;19(suppl 3):S72-S78. (Pubitemid 41682172)
13. Devlin KN, Gongvatana A, Clark US, et al. Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc. 2012;18:68-78.
14. Persidsky Y, Ho W, Ramirez SH, et al. HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. Brain Behav Immun. 2011;25(suppl 1):S61-S70.
15. First M, Spitzer R, Williams J, et al. Structured Clinical Interview for DSM-IV (SCID-I; Patient Version ed.). New York, NY: New York State Psychiatric Institute, Biometrics Research; 1996.
16. Sun B, Abadjian L, Rempel H, et al. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapytreated subjects with human immunodeficiency virus type 1 infection. J Neurovirol. 2010;16:115-124.
17. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
18. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
19. Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307-319. (Pubitemid 39277061)
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57: 125-133.
21. Ihaka R, Gentleman R. R. A language for data analysis and graphics. J Comput Graph Stat. 1996;5:299-314.
22. Rempel H, Sun B, Calosing C, et al. Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS. 2010; 24:1415-1423.
23. Struss DT, Stethem LL, Poirier CA. Comparison of three tests of attention and rapid information processing across six age groups. Clin Neuropsychol. 1987;1:139-152. (Pubitemid 17071446)
24. Smith A. Symbol Digit Modalities Test (SDMT) Manual. Revised ed. Los Angeles, CA: Western Psychological Services; 1982.
25. Golden CJ. Stroop Color and Work Test. Chicago, IL: Stoelting; 1978.
26. Heaton RK, Chelune GJ, Talley JL, et al. Wisconsin Cart Sorting Test (WCST) manual. Revised and expanded ed. Odessa, FL: Psychological Assessment Resources; 1993.
27. Klove H. Clinical neuropsychology. In: Foster FM, ed. The Medical Clinics of North America. New York, NY: Saunders; 1963.
28. Halstead W. Brain and Intelligence. Chicago, IL: University of Chicago Press; 1947.
29. Benton AL, Hamsher K, Sivan AB. Multilingual Aphasia Examination. 3rd ed. Iowa City, IA: AJA Associates; 1983.
30. Benedict RH. Brief Visuospatial Memory Test - Revised (BVMT-R). Odessa, FL: Psychological Assessment Resources, Inc; 1997.
31. Delis DC, Kaplan E, Kramer JH, et al. California Verbal Learning Test -Second Edition (CVLT-II). San Antonio, TX: The Psychological Corporation; 1987.
32. Crystal H, Kleyman I, Anastos K, et al. Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2012;59:149-154.
33. Winston A, Garvey L, Scotney E, et al. Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals? J Viral Hepat. 2010;17:419-426.
34. McAndrews MP, Farcnik K, Carlen P, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology. 2005;41:801-808. (Pubitemid 40462942)
35. Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol. 2009;83:1312-1319.
36. Letendre S, Paulino AD, Rockenstein E, et al. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis. 2007;196:361-370. (Pubitemid 47093886)
37. Forton DM, Hamilton G, Allsop JM, et al. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol. 2008;49:316-322.
38. Grover VP, Pavese N, Koh SB, et al. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat. 2012;19:e89-e96.